US Stock Market Closed

Dashboard

Bristol-Myers Squibb Co. (BMY)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

S

Leverage & Liquidity

S

Fundamental Variables

H

Rating Performance

FV Performance

About

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

CEO

Giovanni Caforio

Employees

30,000

Industry

Oncology Biopharmaceuticals

Sector

Healthcare

Headquarters

New York

Exchange

New York Stock Exchange

Summary Stats

Market Cap

155B

Revenue

46.7B

Net Income

6.68B

EPS

$3.08

Price-to-Earnings

23.63

Price-to-Book

4.74

Debt-to-Equity

2.01

News

Analyst Ratings

Price targets projected by 16 analysts

High

$88.00

Average

$74.06

Low

$64.00

Ratings calculated by 20 analysts

Buy

14

Hold

6

Sell

0

Last Dividend

Amount

$0.57

Dividend Date

Frequency

quarterly

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q4 2022

Last Earnings

Above by $0.10

Actual

$1.82 +5.8%

Consensus

1.72

Report Date

Year Ago

1.83

Year Ago Change %

Up 0%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites